General Stability | Organism |
---|---|
relatively stable to rapid freezing in the presence of 20% glycerol. 90% of the activity remains after each freeze-thaw cycle | Xenopus laevis |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
antipain | 0.05 mM, 35% inhibition | Xenopus laevis | |
Aprotinin | 0.05 mM, 97% inhibition | Xenopus laevis | |
diisopropyl fluorophosphate | 0.05 mM, 37% inhibition. Rapid and irreverible | Xenopus laevis | |
EDTA | 0.05 mM, 90% inhibition | Xenopus laevis | |
EGTA | 0.05 mM, 94% inhibition | Xenopus laevis | |
guanidine hydrochloride | competitive | Xenopus laevis | |
leupeptin | 0.05 mM, 55% inhibition | Xenopus laevis | |
additional information | no inhibition by iodoacetamide, E-64, pepstatin or 1,10-phenanthroline | Xenopus laevis | |
p-aminobenzamidine | competitive | Xenopus laevis | |
Soybean trypsin inhibitor | 0.0025 mM, 84% inhibition | Xenopus laevis |
KM Value [mM] | KM Value Maximum [mM] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|
0.058 | - |
Nalpha-tert-butoxycarbonylphenylalanylserylarginyl-7-amido-4-methylcoumarin | - |
Xenopus laevis |
Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|
secretory granule | oviductal | Xenopus laevis | 30141 | - |
Metals/Ions | Comment | Organism | Structure |
---|---|---|---|
Ca2+ | 38% stimulation at 10 mM. 11% stimulation at 100 mM | Xenopus laevis | |
KCl | maximal activity in 200-400 mM solution of monovalent salts is 200% of that in absence of added salt | Xenopus laevis | |
LiCl | maximal activity in 200-400 mM solution of monovalent salts is 200% of that in absence of added salt | Xenopus laevis | |
NaCl | maximal activity in 200-400 mM solution of monovalent salts is 200% of that in absence of added salt | Xenopus laevis | |
NaF | maximal activity in 200-400 mM solution of monovalent salts is 200% of that in absence of added salt | Xenopus laevis | |
NaNO3 | maximal activity in 200-400 mM solution of monovalent salts is 200% of that in absence of added salt | Xenopus laevis |
Molecular Weight [Da] | Molecular Weight Maximum [Da] | Comment | Organism |
---|---|---|---|
66000 | - |
x * 66000, SDS-PAGE under both nonreducing and reducing conditions | Xenopus laevis |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
gp43 + H2O | Xenopus laevis | preferential cleavage at Gly-Ser-Arg373-/-glycoprotein gp43 in Xenopus laevis coelemic egg envelope to yield gp41. Processing of gp43 causes physical changes in the egg envelope which occurs during egg transit through the oxiduct | gp41 + ? | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Xenopus laevis | - |
- |
- |
Purification (Comment) | Organism |
---|---|
- |
Xenopus laevis |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
oviduct | secretory granules | Xenopus laevis | - |
Specific Activity Minimum [µmol/min/mg] | Specific Activity Maximum [µmol/min/mg] | Comment | Organism |
---|---|---|---|
2.53 | - |
- |
Xenopus laevis |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
gp43 + H2O | preferential cleavage at Gly-Ser-Arg373-/-glycoprotein gp43 in Xenopus laevis coelemic egg envelope to yield gp41. Processing of gp43 causes physical changes in the egg envelope which occurs during egg transit through the oxiduct | Xenopus laevis | gp41 + ? | - |
? | |
gp43 + H2O | preferential cleavage at Gly-Ser-Arg373-/-glycoprotein gp43 in Xenopus laevis coelemic egg envelope to yield gp41 | Xenopus laevis | gp41 + ? | - |
? | |
Nalpha-tert-butoxycarbonyl-Leu-Ser-Thr-Arg-4-methylcoumarin-7-amide + H2O | 14% of the activity with Nalpha-tert-butoxycarbonyl-Phe-Ser-Arg-4-methylcoumarin-7-amide | Xenopus laevis | Nalpha-tert-butoxycarbonyl-Leu-Ser-Thr-Arg + 7-amino-4-methylcoumarin | - |
? | |
Nalpha-tert-butoxycarbonyl-Leu-Thr-Arg-4-methylcoumarin-7-amide + H2O | 12% of the activity with Nalpha-tert-butoxycarbonyl-Phe-Ser-Arg-4-methylcoumarin-7-amide | Xenopus laevis | Nalpha-tert-butoxycarbonyl-Leu-Thr-Arg + 7-amino-4-methylcoumarin | - |
? | |
Nalpha-tert-butoxycarbonyl-Phe-Ser-Arg-4-methylcoumarin-7-amide + H2O | - |
Xenopus laevis | Nalpha-tert-butoxycarbonyl-Phe-Ser-Arg + 7-amino-4-methylcoumarin | - |
? | |
Nalpha-tert-butoxycarbonylphenylalanylserylarginyl-7-amido-4-methylcoumarin + H2O | - |
Xenopus laevis | Nalpha-tert-butoxycarbonylphenylalanylserylarginine + 7-amino-4-methylcoumarin | - |
? | |
Pro-Phe-Arg-4-methylcoumarin-7-amide + H2O | 9% of the activity with Nalpha-tert-butoxycarbonyl-Phe-Ser-Arg-4-methylcoumarin-7-amide | Xenopus laevis | Pro-Phe-Arg + 7-amino-4-methylcoumarin | - |
? | |
Pyr-Gly-Arg-4-methylcoumarin-7-amide + H2O | 9% of the activity with Nalpha-tert-butoxycarbonyl-Phe-Ser-Arg-4-methylcoumarin-7-amide | Xenopus laevis | Pyr-Gly-Arg + 7-amino-4-methylcoumarin | - |
? |
Subunits | Comment | Organism |
---|---|---|
? | x * 66000, SDS-PAGE under both nonreducing and reducing conditions | Xenopus laevis |
Synonyms | Comment | Organism |
---|---|---|
Gp43 processing protease | - |
Xenopus laevis |
oviductal protease | - |
Xenopus laevis |
Turnover Number Minimum [1/s] | Turnover Number Maximum [1/s] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|
3.8 | - |
Nalpha-tert-butoxycarbonylphenylalanylserylarginyl-7-amido-4-methylcoumarin | - |
Xenopus laevis |
pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|
8 | - |
Nalpha-tert-butoxycarbonylphenylalanylserylarginyl-4-methylcoumarin-7-amide | Xenopus laevis |
pH Minimum | pH Maximum | Comment | Organism |
---|---|---|---|
7.5 | 8.5 | more than 90% of maximal activity at pH 7.5 and at pH 8.5, less than 30% of maximal activity below pH 6.5 | Xenopus laevis |
Ki Value [mM] | Ki Value maximum [mM] | Inhibitor | Comment | Organism | Structure |
---|---|---|---|---|---|
0.0041 | - |
p-aminobenzamidine | - |
Xenopus laevis | |
0.0075 | - |
guanidine hydrochloride | - |
Xenopus laevis |